Katharine E. Spink
2015
In 2015, Katharine E. Spink earned a total compensation of $991K as Vice President and Chief Operating Officer at Asterias Biotherapeutics, a 278% increase compared to previous year.
Compensation breakdown
| Option Awards | $622,848 |
|---|---|
| Salary | $267,500 |
| Stock Awards | $87,432 |
| Other | $13,250 |
| Total | $991,030 |
Spink received $622.8K in option awards, accounting for 63% of the total pay in 2015.
Spink also received $267.5K in salary, $87.4K in stock awards and $13.3K in other compensation.
Rankings
In 2015, Katharine E. Spink's compensation ranked 7,978th out of 13,638 executives tracked by ExecPay. In other words, Spink earned more than 41.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,978 out of 13,638 | 42nd |
Division Manufacturing | 3,036 out of 5,187 | 42nd |
Major group Chemicals And Allied Products | 1,095 out of 1,857 | 41st |
Industry group Drugs | 883 out of 1,531 | 42nd |
Industry Biological Products, Except Diagnostic Substances | 155 out of 260 | 40th |
Source: SEC filing on May 1, 2017.
Spink's colleagues
We found two more compensation records of executives who worked with Katharine E. Spink at Asterias Biotherapeutics in 2015.